#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Athanasios Tsiatis Email
SVP, Clinical Development . ALX Oncology
Burlingame, CA
LocationPrimary Email
How to contact Athanasios Tsiatis
Join and see Athanasios's contact info for free!Phone
Current Roles
Employees:
72Revenue:
$8.4MAbout
ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. ALX Oncology’s lead product candidate, ALX148, is a next generation CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated, proprietary Fc domain. ALX148 has demonstrated promising clinical responses across a range of hematologic and solid malignancies in combination with a number of leading anti-cancer agents.ALX Oncology Address
866 Malcolm RoadBurlingame, CA
Ireland